Transchem

Transchem FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Transchem (500422.BO) as of Oct 21, 2026 is -37.01 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 688.83 % — a change of -105.37% (lower).

FCF Conversion

-37.01 %

YoY

-105.37%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Transchem is 2026 -37.01 % . FCF Conversion Rate (FCF/EBITDA) of Transchem was 2025 688.83 % . It decreases by -105.37% lower compared to the previous year.

The Transchem FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
3,387.37 INR
Jan 1, 2020
-154.55 INR
Jan 1, 2021
-115.12 INR
Jan 1, 2022
763.87 INR
Jan 1, 2023
98.55 INR
Jan 1, 2024
-935.18 INR
Jan 1, 2025
688.83 INR
Jan 1, 2026
-37.01 INR
The Transchem FCF Conversion history
YEARFCF ConversionYoY
-37.01 %-105.37%
688.83 %-173.66%
-935.18 %-1,048.91%
98.55 %-87.10%
763.87 %-763.55%
-115.12 %-25.51%
-154.55 %-104.56%
3,387.37 %+103.62%
1,663.55 %-759.06%
-252.41 %-111.32%
2,229.12 %+158.79%
861.37 %-1,299.90%
-71.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

FCF Conversion Rate (FCF/EBITDA) of Transchem is -37.01 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Transchem changed from 688.83 % to -37.01 %, representing a -105.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Transchem since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Transchem with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Transchem

All Key Metrics — Transchem